Healthcare Marketing Agency

What actually governs healthcare marketing in India

Most agencies pitching healthcare treat compliance as a legal review at the end. It belongs at the brief, because it determines what can be said at all.

The framework is layered, and it tightened recently:

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertising claims of efficacy for a schedule of specific conditions, and broadly bars false or misleading statements about therapeutic benefit.

The Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017 govern what may be said about products themselves. Prescription drugs cannot be advertised to the public without prior Central Government approval: a line that a surprising amount of "patient education" content walks up to without realising.

The Uniform Code for Pharmaceutical Marketing Practices, 2024 and the parallel Uniform Code for Marketing Practices in Medical Devices, 2024 are the newest layer and the one most marketing teams haven't fully absorbed. Among other things they cap gifts to healthcare professionals at ₹1,000 per item and tightly limit free sample distribution.

The Consumer Protection Act, 2019 gives the Central Consumer Protection Authority real enforcement power over misleading advertising, with penalties that make this a board-level risk rather than a marketing one.

ASCI sits over all of it as the self-regulatory body, and its rulings move faster than legislation does.

None of that means healthcare brands can't market. It means the work has to be built knowing where the lines are, which is a competence, not a limitation.

Hospital and multi-specialty marketing

Hospital marketing has a structural problem most categories don't: the institution markets, but the patient chooses a doctor. A hospital brand that speaks only at the institutional level (accreditations, bed count, equipment) competes on parity claims every competitor also makes, while the actual decision is happening one specialist at a time.

The work is connecting the two: an institutional brand that means something, and specialist-level visibility underneath it that reaches a patient searching for a specific procedure or condition, without crossing into claims the regulations don't permit.

More on how this works for multi-specialty and single-specialty hospitals on our hospital marketing page.

Specialist practice marketing

Single-specialty practices are, in search terms, the most underserved part of Indian healthcare, and the most winnable. Ophthalmology, dentistry, orthopaedics, dermatology, fertility and cardiology all have distinct patient journeys, distinct decision timelines and almost no well-built specialist marketing competing for them.

A cataract patient, an orthodontic patient and an IVF patient are three completely different buyers with three different anxieties, research patterns and referral dynamics. Treating them as one "healthcare" audience is the most common and most expensive mistake in the category.

We go deeper on the two specialties with the most distinct patient journeys, ophthalmology and dental, and on marketing for individual practitioners.

Pharmaceutical and medical device marketing

Pharma and device marketing operates under the tightest constraints in the entire framework, and, since the 2024 uniform codes, under constraints that changed recently enough that a lot of existing material predates them.

The work here is almost never consumer advertising. It's brand architecture across a product portfolio, communication aimed at healthcare professionals within what the codes permit, medical and scientific communication, and material for a sales force that has to be both persuasive and defensible. Getting this wrong isn't a marketing problem. It's a regulatory exposure.

More detail on our pharmaceutical marketing page.

Digital, search and patient acquisition

Patients research extensively before they book, and the research starts with a symptom, not a brand. That means search visibility on condition-level and procedure-level terms is where healthcare demand actually lives, and it's a discipline that has to be executed inside the same compliance frame as everything else, since a landing page making an unsupportable efficacy claim is exposed exactly the same way a print ad would be.

We cover the mechanics of paid and organic acquisition in more depth on our digital marketing and performance marketing pages. What changes in healthcare is not the channel: it's what you're permitted to say once you're in it.

Brand and identity for healthcare organisations

Underneath the campaigns, most Indian healthcare brands have never had the strategic layer built. Positioning, naming across a group or portfolio, visual identity, and the guidelines that hold a hospital's material together across signage, forms, digital and departmental collateral produced by people who have never spoken to a designer.

Healthcare produces more unmanaged material than almost any other category, which makes it one of the categories where a real guidelines system pays back fastest. That's the core of what we do: more on our homepage.

What determines the cost

We don't publish rates. What moves the number here:

Scope across the organisation. A single-specialty clinic is a different engagement from a multi-specialty hospital group with departmental sub-brands.

Whether compliance review is in scope. Building material to a regulatory standard is a different level of work from producing material and hoping it clears.

How much existing material needs auditing. Groups with years of accumulated collateral produced before the 2024 codes often need a review pass before anything new is built.

Digital scope. Brand and identity alone, versus brand plus ongoing search and acquisition work.

Tell us what you're solving and we'll give you a real read before anything is committed.